Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist.

MLA

Guleria, Sonia, et al. “Comparing Regulatory Guidance on Risk Minimization/Mitigation and the Reporting Recommendation Intended for Pharmaceutical Risk Minimization Evaluation Studies Checklist.” British Journal of Clinical Pharmacology, Sept. 2024, p. 1. EBSCOhost, https://doi.org/10.1111/bcp.16259.

APA

Guleria, S., Brouwer, E., Brown, D. A., & Hakkarainen, K. M. (2024). Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist. British Journal of Clinical Pharmacology, 1. https://doi.org/10.1111/bcp.16259

Chicago

Guleria, Sonia, Emily Brouwer, David A. Brown, and Katja M. Hakkarainen. 2024. “Comparing Regulatory Guidance on Risk Minimization/Mitigation and the Reporting Recommendation Intended for Pharmaceutical Risk Minimization Evaluation Studies Checklist.” British Journal of Clinical Pharmacology, September, 1. doi:10.1111/bcp.16259.